Literature DB >> 18212227

Percutaneous imaging-guided solid organ core needle biopsy: coaxial versus noncoaxial method.

Malcolm K Hatfield1, Robert A Beres, Shekhar S Sane, George X Zaleski.   

Abstract

OBJECTIVE: The purpose of our study was to compare the diagnostic yield and complication rate of coaxial technique with those of noncoaxial technique in percutaneous imaging-guided renal and hepatic core biopsies. We also compared bleeding complication rates with and without absorbable gelatin sponge occlusion of the biopsy track.
MATERIALS AND METHODS: The records of 1,060 consecutively registered patients who underwent percutaneous imaging-guided hepatic or renal biopsy at two hospitals were retrospectively reviewed. Core specimens were obtained in all biopsies. Indications for biopsy included acquisition of general tissue specimens to evaluate for hepatic (n = 495) or renal disease (n = 243) and acquisition of specimens of specific hepatic (n = 289) and renal (n = 33) lesions. Samples were acquired with a coaxial set of needles (n = 764) or with a noncoaxial needle (n = 296 patients). Absorbable gelatin sponge was injected before removal of the outer needle in 269 of the 764 coaxial biopsies. Gelatin sponge was not injected in the other 495 coaxial biopsies. Complication rates were evaluated in a comparison of the two methods and of the coaxial biopsies with and without postprocedural injection of gelatin sponge. Complications were considered minor if follow-up imaging in the 7 days after the procedure showed a complication that did not necessitate treatment other than conservative pain management. Complications were considered major if treatment such as blood product transfusion or surgery was needed or if the patient died.
RESULTS: Specimens were immediately given to a pathologist, who typically was present during the procedure. Specimens were evaluated and judged adequate for a specific diagnosis by the histopathology staff. The rates of minor complications were 3.4% (10/296) for the noncoaxial method and 2.6% (20/764) for the coaxial method. The rates of major complications were 1.0% (3/296) for the noncoaxial method and 0.9% (7/764) for the coaxial method. Six cases of major complications necessitating blood product transfusion were documented for the coaxial method and one case for the noncoaxial method. One (0.1%) of the patients undergoing coaxial biopsy died. One patient undergoing noncoaxial biopsy needed surgical repair of an arterial injury that was refractory to blood transfusion, and another developed pancreatitis and needed a blood transfusion. The percentage of minor complications of the coaxial method with absorbable gelatin sponge injection was 3.7% (10/269), and that of major complications was 0.7% (2/269). There was no statistical difference in complication rates between the various methods of percutaneous hepatic and renal biopsy.
CONCLUSION: In regard to complications, there are no differences between coaxial and noncoaxial biopsy methods or between the coaxial method with or without injection of absorbable gelatin sponge.

Entities:  

Mesh:

Year:  2008        PMID: 18212227     DOI: 10.2214/AJR.07.2676

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

1.  Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.

Authors:  Guido M Kukuk; Kanishka Hittatiya; Alois M Sprinkart; Holger Eggers; Jürgen Gieseke; Wolfgang Block; Philipp Moeller; Winfried A Willinek; Ulrich Spengler; Jonel Trebicka; Hans-Peter Fischer; Hans H Schild; Frank Träber
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 2.  Lung and Abdominal Biopsies in the Age of Precision Medicine.

Authors:  Leonard Dalag; Jonathan K Fergus; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 3.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

4.  Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy.

Authors:  Gaspard d'Assignies; Anita Paisant; Edouard Bardou-Jacquet; Anne Boulic; Elise Bannier; Fabrice Lainé; Martine Ropert; Jeff Morcet; Hervé Saint-Jalmes; Yves Gandon
Journal:  Eur Radiol       Date:  2017-11-24       Impact factor: 5.315

5.  Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis.

Authors:  Yusuke Ozeki; Naoya Kanogawa; Sadahisa Ogasawara; Keita Ogawa; Takamasa Ishino; Miyuki Nakagawa; Kisako Fujiwara; Hidemi Unozawa; Terunao Iwanaga; Takafumi Sakuma; Naoto Fujita; Ryuta Kojima; Hiroaki Kanzaki; Keisuke Koroki; Kazufumi Kobayashi; Masato Nakamura; Soichiro Kiyono; Takayuki Kondo; Tomoko Saito; Ryo Nakagawa; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Ryosuke Muroyama; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Jun Kato; Jun-Ichiro Ikeda; Yuichi Takiguchi; Naoya Kato
Journal:  Int J Clin Oncol       Date:  2022-06-15       Impact factor: 3.850

6.  Performance of Biopsy Needle With Therapeutic Injection System to Prevent Bleeding Complications.

Authors:  Philip Wong; Kent J Johnson; Roscoe L Warner; Scott I Merz; Grant H Kruger; William F Weitzel
Journal:  J Med Device       Date:  2013-02-04       Impact factor: 0.582

Review 7.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

8.  Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma.

Authors:  Anil Gupta; Rishabh Kumar; Hanuman Prasad Yadav; Manik Sharma; Rose Kamal; Deepak Thaper; Prabir Banik; Shipra Gupta; Kartik Saroha; Sandeep Singh; Shiv Kumar Sarin
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-13

9.  Using X-ray in-line phase-contrast imaging for the investigation of nude mouse hepatic tumors.

Authors:  Qiang Tao; Dongyue Li; Lu Zhang; Shuqian Luo
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

10.  Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.

Authors:  Sundeep Agrawal; Naomi B Haas; Mohammadhadi Bagheri; Brian R Lane; Jonathan Coleman; Hans Hammers; Gennady Bratslavsky; Cynthia Chauhan; Lauren Kim; Venkatesh P Krishnasamy; Jamie Marko; Virginia Ellen Maher; Amna Ibrahim; Frank Cross; Ke Liu; Julia A Beaver; Richard Pazdur; Gideon M Blumenthal; Harpreet Singh; Elizabeth R Plimack; Toni K Choueiri; Robert Uzzo; Andrea B Apolo
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.